Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
- PMID: 21443877
- DOI: 10.1016/j.febslet.2011.03.046
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Abstract
Aggregation of alpha-synuclein (αS) into oligomers is critically involved in the pathogenesis of Parkinson's disease (PD). Using confocal single-molecule fluorescence spectroscopy, we have studied the effects of 14 naturally-occurring polyphenolic compounds and black tea extract on αS oligomer formation. We found that a selected group of polyphenols exhibited potent dose-dependent inhibitory activity on αS aggregation. Moreover, they were also capable of robustly disaggregating pre-formed αS oligomers. Based upon structure-activity analysis, we propose that the key molecular scaffold most effective in inhibiting and destabilizing self-assembly by αS requires: (i) aromatic elements for binding to the αS monomer/oligomer and (ii) vicinal hydroxyl groups present on a single phenyl ring. These findings may guide the design of novel therapeutic drugs in PD.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Generation of ferric iron links oxidative stress to α-synuclein oligomer formation.J Parkinsons Dis. 2011;1(2):205-16. doi: 10.3233/JPD-2011-11040. J Parkinsons Dis. 2011. PMID: 23934922
-
Familial Parkinson disease mutations influence α-synuclein assembly.Neurobiol Dis. 2011 Sep;43(3):715-24. doi: 10.1016/j.nbd.2011.05.025. Epub 2011 Jun 7. Neurobiol Dis. 2011. PMID: 21684335
-
Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.J Neurochem. 2015 Sep;134(5):943-55. doi: 10.1111/jnc.13180. Epub 2015 Jun 17. J Neurochem. 2015. PMID: 26016728
-
Anti-aggregation Effects of Phenolic Compounds on α-synuclein.Molecules. 2020 May 24;25(10):2444. doi: 10.3390/molecules25102444. Molecules. 2020. PMID: 32456274 Free PMC article. Review.
-
Controlling the mass action of alpha-synuclein in Parkinson's disease.J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
Cited by
-
Targeting gasdermin E in neurodegenerative diseases.Cell Rep Med. 2023 Jun 20;4(6):101075. doi: 10.1016/j.xcrm.2023.101075. Cell Rep Med. 2023. PMID: 37343522 Free PMC article.
-
Small molecules in regulating protein phase separation.Acta Biochim Biophys Sin (Shanghai). 2023 Jun 12;55(7):1075-1083. doi: 10.3724/abbs.2023106. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37294104 Free PMC article.
-
Analysis of phenolic compounds in Parkinson's disease: a bibliometric assessment of the 100 most cited papers.Front Aging Neurosci. 2023 May 2;15:1149143. doi: 10.3389/fnagi.2023.1149143. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37205057 Free PMC article. Review.
-
Endophytic Fusarium species, a unique bioresource for disaggregator of misfolded alpha-synuclein.Arch Microbiol. 2023 May 8;205(6):224. doi: 10.1007/s00203-023-03575-z. Arch Microbiol. 2023. PMID: 37155019
-
Mechanistic Insights into Polyphenols' Aggregation Inhibition of α-Synuclein and Related Peptides.ACS Chem Neurosci. 2023 May 17;14(10):1905-1920. doi: 10.1021/acschemneuro.3c00162. Epub 2023 Apr 26. ACS Chem Neurosci. 2023. PMID: 37125909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
